By rray, 26 March, 2024 If low thromboembolic risk AF w CHA2DS2 VASc 3mo prior bioprosthetic valve w o AF 3mo ago discontinuing OAC is reasonable
By rray, 26 March, 2024 Address modifiable bleeding risk factors Check for meds that interfere w OAC levels